ABBV Q3 Earnings Call Highlights Raised Outlook and Pipeline Progress
Published . Updated .
This report does not map to a usual set of affected companies.
Directly affected
- ABBV AbbVie+11.4% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that AbbVie belongs to, so it often moves with news about it.
- LLY Eli Lilly and+21.6% 30d
Eli Lilly and is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+1.5% 30d
Johnson & Johnson is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+4.0% 17d
Merck is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+4.1% 30d
Abbott Laboratories is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
- PFE Pfizer+8.9% 30d
Pfizer is a peer of AbbVie in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ABBV | -0.84% | +0.67% | base | after close | after close | after close | after close |
| XLV | -2.95% | -0.31% | base | after close | after close | after close | after close |
| LLY | -9.22% | -2.71% | base | after close | after close | after close | after close |
| JNJ | -0.68% | +1.70% | base | after close | after close | after close | after close |
| MRK | -4.45% | -1.43% | base | after close | after close | after close | after close |
| ABT | -6.49% | -5.19% | base | after close | after close | after close | after close |
| PFE | -3.00% | -2.47% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
ABBV Q3 Earnings Call Highlights Raised Outlook and Pipeline Progress The Globe and Mail
Source: The Globe and Mail
Energy
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | three days earlier | +0.67% | final price |
| ABBV | five days earlier | -0.84% | final price |
| ABT | three days earlier | -5.19% | final price |
| ABT | five days earlier | -6.49% | final price |
| JNJ | three days earlier | +1.70% | final price |
| JNJ | five days earlier | -0.68% | final price |
| LLY | three days earlier | -2.71% | final price |
| LLY | five days earlier | -9.22% | final price |
| MRK | three days earlier | -1.43% | final price |
| MRK | five days earlier | -4.45% | final price |
| PFE | three days earlier | -2.47% | final price |
| PFE | five days earlier | -3.00% | final price |
| XLV | three days earlier | -0.31% | final price |
| XLV | five days earlier | -2.95% | final price |
Congressional trades in the stocks in this story
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 50 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 56 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 76 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 32 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 46 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
How solid the energy case looks
12 out of 100
“ABBV Q3 Earnings Call Highlights Raised Outlook and Pipeline Progress” scores 12 out of 100. The score uses 1 sources.